Tag: TAAA
The top 10 most popular Vascular Specialist stories of January 2024
In January, the most read stories from Vascular Specialist include a U.S. Aortic Research Consortium analysis of F/BEVAR preoperative risk factors in AAAs/TAAAs; a...
First patient treated in ZFEN+ fenestrated endovascular graft study
Cook Medical has announced the first patient treated in the clinical study of the Zenith Fenestrated+ endovascular graft (ZFEN+) in the U.S. The procedure was...
Gore receives FDA approval for breakthrough endovascular device in complex aortic...
Gore has announced Food and Drug Administration (FDA) approval for the Gore Excluder thoracoabdominal branch endoprosthesis (TAMBE), which the company states is the first...
U.S. Aortic Research Consortium maps out F/BEVAR preoperative risk factors for...
A series of preoperative risk factors—including currently smoking, chronic kidney disease (CKD), congestive heart failure (CHF), aneurysm size greater than 7cm, more advanced...
Preventing spinal cord ischemia: Novel techniques for direct segmental artery revascularization...
A vascular surgery team from the University of Southern California (USC) in Los Angeles demonstrated the feasibility of multidisciplinary direct revascularization of segmental arteries...
First implant of custom-made thoracoabdominal hybrid device in North America announced
Terumo Aortic announced the first North American implant of a custom-made hybrid device, Thoracoflo.
A press release noted that the device is used to treat...
‘Unique’ vascular meeting set to update surgeons, prioritize audience debate
Prioritizing “entertaining and informative” sessions, the 29th Annual Pennsylvania Hospital Vascular Symposium and the 3rd Annual Pennsylvania Hospital/University of Pennsylvania Non-invasive Vascular Laboratory Symposium...
Cydar Medical and King’s College London partner on randomized controlled trial...
Cydar Medical has partnered with King’s College London to initiate the ARIA study—a randomized controlled trial to assess the clinical-, technical- and cost-effectiveness of...
Off-the-shelf branched endograft for TAAAs demonstrates safety and effectiveness through two...
Two-year target vessel-related freedom from all-cause and aneurysm-related mortality for an off-the-shelf multibranched endovascular device for the treatment of thoracoabdominal aortic aneurysms (TAAAs) came...
Vascular Specialist@VAM–Conference Edition 2
Featured in this VAM daily edition:
F/BEVAR has high technical success and low mortality in chronic post-dissection TAAA (p. 1 and 3)
Systemic heparin...
F/BEVAR has high technical success and low mortality in chronic post-dissection...
Fenestrated/branched endovascular aneurysm repair (F/BEVAR) is associated with high technical success and low mortality in patients with chronic post-dissection thoracoabdominal aortic aneurysm (PD-TAAA). This...
‘Endovation’: Guidelines from the front lines
Among the highlights from the “‘Endovation’—Endovascular Innovation for Urgent and Emergency Complex Aortic Disorders” session coming up at the 2022 Vascular Annual Meeting (VAM)...
Cook Medical receives FDA Breakthrough Device designation for Zenith Thoraco+ endovascular...
Cook Medical’s Zenith Thoraco+ endovascular system (Thoraco+) has received Breakthrough Device designation from the Food and Drug Administration (FDA), a press release reports.
The company...
F/BEVAR review reveals less than 20% of patients suffered intraoperative adverse...
A retrospective evaluation of 600 fenestrated or branched endovascular aneurysm repairs (F/BEVARs) for the treatment of complex aneurysms revealed that fewer than one in...
The top 10 most popular Vascular Specialist stories in February
February's top 10 includes a highlight from the 2022 Vascular and Endovascular Surgery Society (VESS) winter annual meeting and an interview with Melissa Kirkwood,...
Patients in Florida with complex aortic pathology gain unique access to...
This advertorial is sponsored by Tampa General Hospital.
Patients with complex pararenal and thoracoabdominal aortic aneurysm (TAAA) disease are faced with limited treatment options outside...
Complex TAAA: US ARC IDE registry reports better survival vs. real-world...
Patients treated in Food and Drug Administration (FDA)-approved investigational device exemption (IDE) trials for complex thoracoabdominal aortic aneurysms (TAAAs) in the U.S. Aortic...
Vascular Specialist–February 2022
In this issue:
"Vital signs": Reporting from the Southern Association for Vascular Surgery (SAVS) annual meeting on skyrocketing nursing costs and their contribution to...
US IDE Aortic Research Consortium ‘pushes the envelope’ on F/BEVAR
The U.S. investigational device exemption (IDE) Aortic Research Consortium has produced the strongest data so far on the use of fenestrated/branched endovascular aneurysm repair...
Hospital wins battle against time for one patient’s aortic emergency
This advertorial is sponsored by Tampa General Hospital.
Aortic emergencies, if not diagnosed and managed in due time, are, of course, life threatening. Responding to...
Clinical evaluation of robotic-assisted peripheral artery intervention in human completed
Aopeng Medical’s Allvas endovascular intervention surgical robot has successfully carried out a first-in-human clinical evaluation of a robot-assisted peripheral artery intervention of an iliac...
Sanford invents Breakthrough Device for TAAA
An investigational device invented at Sanford Health in Sioux Falls, South Dakota, that helps high-risk vascular disease patients has been granted a Breakthrough Device...
Lead vascular surgeon on first use of Fiber Optic RealShape in...
Vascular surgeons at the University of Massachusetts became the first in the United States to carry out procedures using the breakthrough imaging technology Fiber...
Journal supplement outlines updated clinical practice guidelines, reporting standards
The Society for Vascular Surgery (SVS) is starting 2021 with updated clinical practice guidelines and reporting standards for three vascular conditions.
Guidelines on chronic mesenteric...
F-BEVAR performed on women shows ‘lower’ level of technical success
Fenestrated-branched endovascular aneurysm repair (F-BEVAR) for thoracoabdominal aortic aneurysms (TAAAs) carried out on women “demonstrate metrics of increased complexity and have a lower level...
‘No evidence’ to suggest spinal cord injury is decreased by prophylactic...
MIAMI—Cerebrospinal fluid (CSF) drainage is a key component in the treatment of spinal cord injury but the evidence that prophylactic drainage decreases such injury...